Breaking News Instant updates and real-time market news.

GM

General Motors

$35.72 /

+0.72 (+2.06%)

06:36
10/25/22
10/25
06:36
10/25/22
06:36

General Motors issues letter to shareholders regarding Q3 results

The letter said, "During the third quarter, GM once again delivered strong results, including record third-quarter revenue and double-digit EBIT-adjusted margins. We're delivering on our commitments and affirming our full-year guidance despite a challenging environment because demand continues to be strong for GM products and we are actively managing the headwinds we face. For example, our team translated improved supply chain conditions into another quarter of full-size pickup, full-size SUV and Cadillac Escalade segment leadership. This keeps us on track to deliver our third consecutive year of full-size pickup leadership, and our 22nd year as the full-size SUV leader. To build our truck leadership and help maintain our strong margins, Chevrolet and GMC recently unveiled new midsize and heavy-duty pickups that will launch next year. We also earned more than 8% of the U.S. electric vehicle market in the third quarter thanks to record sales of the Chevrolet Bolt EV and Bolt EUV. Our dealers and customers have embraced the Bolt because of its range, technology and value, helping it outsell Ford's Mach-E by more than two to one in September. The Chevrolet Equinox EV and the GMC Sierra EV that we revealed in recent weeks, along with the Chevrolet Silverado EV and Blazer EV, are cornerstones of our strategy to rapidly grow EV volumes by winning in high-volume segments. They have all been incredibly well received by customers and industry experts who see them driving rapid EV adoption and conquest sales for GM, including in coastal markets. The Chevrolet Bolt EV and Bolt EUV will continue to play an important role too. We're increasing production from 44,000 units this year to 70,000 units next year, and we will leverage our industry-leading loyalty to move these customers into one of our new EVs for their next purchase. As we scale the Ultium Platform, we have been very intentional to position the company for volume growth with flexibility, efficiency and increased EV profitability over time. Greater vertical integration is a key driver. That's why we are building battery cells in Ohio through Ultium Cells LLC, with a second U.S. plant opening next year, a third in 2024 and a fourth planned. A secure and integrated supply chain will be another competitive advantage for us as we scale. As I shared last quarter, we moved early and aggressively to secure commitments for all the battery raw material we need to reach more than 1 million units of annual EV capacity in North America in 2025. For growth beyond 2025, we continue to secure our future with strategic supply agreements and direct investments in natural resource recovery, processing and recycling. There have been many other exciting developments, but it's the Cadillac CELESTIQ we unveiled on Oct. 17 that shows the almost limitless possibilities of Ultium. The CELESTIQ is a completely bespoke work of automotive art built around the most advanced and innovative technology that we have ever engineered. No two will be alike and we will begin handcrafting them in December 2023. This is a very exciting time for GM. That's why I'd like to encourage all of you to join our Investor Day webcast on Nov. 17. We will use this time to go deeper into the rapid scaling of our EV portfolio and we'll share important metrics to help you track our progress."

  • 25

    Oct

OTHER BREAKING NEWS FROM THE FLY

Downgrade
Davide Campari-Milano downgraded to Neutral from Overweight at JPMorgan » 04:57
12/01/22
12/01
04:57
12/01/22
04:57
DVDCF

Davide Campari-Milano

$10.90 /

+ (+0.00%)

JPMorgan analyst Celine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DVDCF Davide Campari-Milano
$10.90 /

+ (+0.00%)

11/08/22 Morgan Stanley
Davide Campari-Milano price target lowered to EUR 9.30 at Morgan Stanley
11/02/22 Societe Generale
Davide Campari-Milano price target lowered to EUR 12 at Societe Generale
11/01/22 Credit Suisse
Davide Campari-Milano price target lowered to EUR 10 from EUR 11.90 at Credit Suisse
11/01/22 Deutsche Bank
Davide Campari-Milano upgraded to Buy from Hold at Deutsche Bank
Downgrade
L'Oreal downgraded to Neutral from Overweight at JPMorgan » 04:56
12/01/22
12/01
04:56
12/01/22
04:56
LRLCY

L'Oreal

$74.41 /

+2.458 (+3.42%)

JPMorgan analyst Celine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LRLCY L'Oreal
$74.41 /

+2.458 (+3.42%)

LRLCY L'Oreal
$74.41 /

+2.458 (+3.42%)

10/25/22 Berenberg
L'Oreal price target lowered to EUR 314 from EUR 347 at Berenberg
10/24/22 Barclays
L'Oreal price target lowered to EUR 375 from EUR 416 at Barclays
10/11/22 Morgan Stanley
L'Oreal price target lowered to EUR 365 from EUR 385 at Morgan Stanley
10/11/22 Deutsche Bank
L'Oreal price target lowered to EUR 380 from EUR 400 at Deutsche Bank
LRLCY L'Oreal
$74.41 /

+2.458 (+3.42%)

Conference/Events
Standard Motor management to meet virtually with MKM Partners » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
SMP

Standard Motor

$38.37 /

+0.6 (+1.59%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SMP Standard Motor
$38.37 /

+0.6 (+1.59%)

SMP Standard Motor
$38.37 /

+0.6 (+1.59%)

10/18/22 MKM Partners
Standard Motor price target lowered to $47 from $57 at MKM Partners
06/09/22 MKM Partners
Standard Motor initiated with a Buy at MKM Partners
SMP Standard Motor
$38.37 /

+0.6 (+1.59%)

SMP Standard Motor
$38.37 /

+0.6 (+1.59%)

Conference/Events
Senate Agriculture, Nutrition & Forrestry Committee to hold a hearing » 04:55
12/01/22
12/01
04:55
12/01/22
04:55

The Committee holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Humana to participate in a conference call with Mizuho » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
HUM

Humana

$550.14 /

+16.53 (+3.10%)

Conference call to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HUM Humana
$550.14 /

+16.53 (+3.10%)

HUM Humana
$550.14 /

+16.53 (+3.10%)

11/08/22 Wells Fargo
Humana price target raised to $610 from $558 at Wells Fargo
11/07/22 Cowen
Humana price target raised to $647 from $547 at Cowen
11/03/22 Truist
Humana price target raised to $650 from $570 at Truist
11/03/22 RBC Capital
Humana price target raised to $637 from $560 at RBC Capital
HUM Humana
$550.14 /

+16.53 (+3.10%)

HUM Humana
$550.14 /

+16.53 (+3.10%)

HUM Humana
$550.14 /

+16.53 (+3.10%)

HUM Humana
$550.14 /

+16.53 (+3.10%)

Conference/Events
Intellia Therapeutics to participate in a conference call with JPMorgan » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
NTLA

Intellia Therapeutics

$51.41 /

+3.44 (+7.17%)

SMid Cap Biotech Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTLA Intellia Therapeutics
$51.41 /

+3.44 (+7.17%)

NTLA Intellia Therapeutics
$51.41 /

+3.44 (+7.17%)

11/14/22 Chardan
Intellia Therapeutics price target raised to $129 from $121 at Chardan
11/03/22 Chardan
Intellia Therapeutics price target lowered to $121 from $146 at Chardan
10/31/22 EF Hutton
Intellia Therapeutics initiated with a Buy at EF Hutton
10/11/22 Morgan Stanley
Intellia Therapeutics initiated with an Overweight at Morgan Stanley
NTLA Intellia Therapeutics
$51.41 /

+3.44 (+7.17%)

  • 01
    Dec
NTLA Intellia Therapeutics
$51.41 /

+3.44 (+7.17%)

NTLA Intellia Therapeutics
$51.41 /

+3.44 (+7.17%)

Conference/Events
UBS semiconductor analyst to hold an analyst/industry conference call » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
ADI

Analog Devices

$171.83 /

+7.89 (+4.81%)

Semiconductors Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
ADI Analog Devices
$171.83 /

+7.89 (+4.81%)

ADI Analog Devices
$171.83 /

+7.89 (+4.81%)

11/23/22 Deutsche Bank
Analog Devices price target raised to $170 from $155 at Deutsche Bank
11/23/22 Evercore ISI
Analog Devices price target raised to $195 from $185 at Evercore ISI
11/23/22 Truist
Analog Devices price target raised to $214 from $209 at Truist
11/23/22 Cowen
Analog Devices price target raised to $190 from $180 at Cowen
ADI Analog Devices
$171.83 /

+7.89 (+4.81%)

ADI Analog Devices
$171.83 /

+7.89 (+4.81%)

ADI Analog Devices
$171.83 /

+7.89 (+4.81%)

Hot Stocks
Sabre to replace Flagstar Bancorp in the S&P 600 at open on 12/1 » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
SABR

Sabre

$6.10 /

+0.325 (+5.63%)

, FBC

Flagstar Bancorp

$37.55 /

+0.45 (+1.21%)

Nexstar Media Group…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SABR Sabre
$6.10 /

+0.325 (+5.63%)

FBC Flagstar Bancorp
$37.55 /

+0.45 (+1.21%)

SABR Sabre
$6.10 /

+0.325 (+5.63%)

10/17/22 Mizuho
Sabre price target lowered to $6 from $7 at Mizuho
09/28/22 Redburn
Sabre initiated with a Buy at Redburn
09/08/22 Mizuho
Sabre price target lowered to $7 from $8 at Mizuho
08/22/22 Mizuho
Sabre price target raised to $8 from $7 at Mizuho
FBC Flagstar Bancorp
$37.55 /

+0.45 (+1.21%)

07/11/22 B. Riley
Flagstar Bancorp price target lowered to $40 from $44 at B. Riley
06/14/22 B. Riley
Flagstar Bancorp downgraded to Neutral from Buy at B. Riley
06/14/22 B. Riley
Flagstar Bancorp downgraded to Neutral from Buy at B. Riley
06/02/22 Keefe Bruyette
New York Community downgraded to Market Perform at Keefe Bruyette
SABR Sabre
$6.10 /

+0.325 (+5.63%)

FBC Flagstar Bancorp
$37.55 /

+0.45 (+1.21%)

SABR Sabre
$6.10 /

+0.325 (+5.63%)

FBC Flagstar Bancorp
$37.55 /

+0.45 (+1.21%)

SABR Sabre
$6.10 /

+0.325 (+5.63%)

SABR Sabre
$6.10 /

+0.325 (+5.63%)

Conference/Events
CCC Intelligent Solutions management to meet with Piper Sandler » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
CCCS

CCC Intelligent Solutions

$9.18 /

+0.31 (+3.50%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CCCS CCC Intelligent Solutions
$9.18 /

+0.31 (+3.50%)

11/01/22 Citi
CCC Intelligent Solutions price target lowered to $10 from $11 at Citi
10/21/22 Barclays
CCC Intelligent Solutions initiated with an Equal Weight at Barclays
08/08/22 Piper Sandler
CCC Intelligent Solutions initiated with a Neutral at Piper Sandler
07/13/22 Goldman Sachs
CCC Intelligent Solutions upgraded to Buy from Neutral at Goldman Sachs
CCCS CCC Intelligent Solutions
$9.18 /

+0.31 (+3.50%)

  • 07
    Apr
Conference/Events
S&P Global to host investor day » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
SPGI

S&P Global

$352.79 /

+6.24 (+1.80%)

Investor Day to be held…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPGI S&P Global
$352.79 /

+6.24 (+1.80%)

SPGI S&P Global
$352.79 /

+6.24 (+1.80%)

11/28/22 BMO Capital
S&P Global price target raised to $393 from $355 at BMO Capital
11/07/22 Atlantic Equities
Atlantic upgrades S&P Global to Overweight on 'high-quality' business
11/07/22 Atlantic Equities
S&P Global upgraded to Overweight from Neutral at Atlantic Equities
11/01/22 Argus
S&P Global price target lowered to $365 from $420 at Argus
SPGI S&P Global
$352.79 /

+6.24 (+1.80%)

SPGI S&P Global
$352.79 /

+6.24 (+1.80%)

Conference/Events
Needham healthcare analyst to hold an analyst/industry conference call » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
ALC

Alcon

$68.89 /

+1.585 (+2.36%)

, BLCO

Bausch + Lomb

$15.13 /

+0.61 (+4.20%)

, COO

Cooper Companies

$316.13 /

+8.85 (+2.88%)

, GKOS

Glaukos

$46.51 /

+0.84 (+1.84%)

, JNJ

Johnson & Johnson

$177.94 /

+1.895 (+1.08%)

, RXST

RxSight

$12.75 /

+0.64 (+5.28%)

, SGHT

Sight Sciences

$11.08 /

+0.53 (+5.02%)

, STAA

Staar Surgical

$57.04 /

+1.61 (+2.90%)

Healthcare Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALC Alcon
$68.89 /

+1.585 (+2.36%)

BLCO Bausch + Lomb
$15.13 /

+0.61 (+4.20%)

COO Cooper Companies
$316.13 /

+8.85 (+2.88%)

GKOS Glaukos
$46.51 /

+0.84 (+1.84%)

JNJ Johnson & Johnson
$177.94 /

+1.895 (+1.08%)

SGHT Sight Sciences
$11.08 /

+0.53 (+5.02%)

STAA Staar Surgical
$57.04 /

+1.61 (+2.90%)

ALC Alcon
$68.89 /

+1.585 (+2.36%)

11/21/22 Credit Suisse
Alcon price target lowered to CHF 80 from CHF 84 at Credit Suisse
11/17/22 Societe Generale
Societe Generale downgrades Alcon to Sell with Q3 'last good quarter'
11/17/22 Societe Generale
Alcon downgraded to Sell from Hold at Societe Generale
11/17/22 Wells Fargo
Alcon price target lowered to $83 from $90 at Wells Fargo
BLCO Bausch + Lomb
$15.13 /

+0.61 (+4.20%)

11/03/22 H.C. Wainwright
Bausch + Lomb price target lowered to $20 from $21 at H.C. Wainwright
09/12/22 H.C. Wainwright
Bausch + Lomb initiated with a Buy at H.C. Wainwright
07/28/22 RBC Capital
RBC says court ruling on Xifaxan looks like 'worst possible outcome' for Bausch
07/28/22 JPMorgan
JPMorgan downgrades Bausch on 'near-worst-case scenario' ruling
COO Cooper Companies
$316.13 /

+8.85 (+2.88%)

11/30/22 Baird
Cooper Companies upgraded to Outperform from Neutral at Baird
11/28/22 JPMorgan
Cooper Companies price target raised to $330 from $300 at JPMorgan
11/03/22 Piper Sandler
Cooper Companies price target lowered to $355 from $375 at Piper Sandler
10/11/22 Jefferies
Cooper Companies downgraded to Hold from Buy at Jefferies
GKOS Glaukos
$46.51 /

+0.84 (+1.84%)

11/03/22 Piper Sandler
Glaukos price target raised to $60 from $55 at Piper Sandler
10/13/22 Stephens
Glaukos resumed with an Overweight at Stephens
10/12/22 Piper Sandler
CMS proposal a positive for Med Tech sector, says Piper Sandler
10/05/22 Citi
Glaukos price target raised to $57 from $54 at Citi
JNJ Johnson & Johnson
$177.94 /

+1.895 (+1.08%)

11/30/22 Wells Fargo
Horizon Therapeutics takeover value could be $135/share, says Wells Fargo
11/29/22 Craig-Hallum
Craig-Hallum sees potential for competing Apollo Endosurgery bids
11/28/22 Morgan Stanley
Genmab risk/reward favorable into arbitration ruling, says Morgan Stanley
11/17/22 Credit Suisse
Johnson & Johnson initiated with a Neutral at Credit Suisse
RXST RxSight
$12.75 /

+0.64 (+5.28%)

10/11/22 BofA
RxSight reinstated with a Buy at BofA
04/19/22 BTIG
J&J results will be viewed favorably for MedTech group, says BTIG
04/08/22 Needham
RxSight initiated with a Buy at Needham
SGHT Sight Sciences
$11.08 /

+0.53 (+5.02%)

10/12/22 Piper Sandler
CMS proposal a positive for Med Tech sector, says Piper Sandler
10/11/22 BofA
Sight Sciences reinstated with a Neutral at BofA
10/05/22 Citi
Sight Sciences price target lowered to $9 from $13 at Citi
10/04/22 Needham
Sight Sciences initiated with a Hold at Needham
STAA Staar Surgical
$57.04 /

+1.61 (+2.90%)

11/30/22 Canaccord
Staar Surgical price target lowered to $79 from $88 at Canaccord
11/07/22 Sidoti
Staar Surgical upgraded to Buy from Neutral at Sidoti
11/03/22 Needham
Staar Surgical price target lowered to $83 from $110 at Needham
11/03/22 BTIG
Staar Surgical price target lowered to $80 from $103 at BTIG
ALC Alcon
$68.89 /

+1.585 (+2.36%)

BLCO Bausch + Lomb
$15.13 /

+0.61 (+4.20%)

COO Cooper Companies
$316.13 /

+8.85 (+2.88%)

GKOS Glaukos
$46.51 /

+0.84 (+1.84%)

JNJ Johnson & Johnson
$177.94 /

+1.895 (+1.08%)

RXST RxSight
$12.75 /

+0.64 (+5.28%)

SGHT Sight Sciences
$11.08 /

+0.53 (+5.02%)

STAA Staar Surgical
$57.04 /

+1.61 (+2.90%)

  • 06
    May
JNJ Johnson & Johnson
$177.94 /

+1.895 (+1.08%)

ALC Alcon
$68.89 /

+1.585 (+2.36%)

BLCO Bausch + Lomb
$15.13 /

+0.61 (+4.20%)

COO Cooper Companies
$316.13 /

+8.85 (+2.88%)

GKOS Glaukos
$46.51 /

+0.84 (+1.84%)

JNJ Johnson & Johnson
$177.94 /

+1.895 (+1.08%)

JNJ Johnson & Johnson
$177.94 /

+1.895 (+1.08%)

RXST RxSight
$12.75 /

+0.64 (+5.28%)

Conference/Events
BTIG medical technology analyst to hold analyst/industry conference call » 04:55
12/01/22
12/01
04:55
12/01/22
04:55

Medical Technology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
C.H. Robinson management to meet with Stephens » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
CHRW

C.H. Robinson

$99.61 /

+2.615 (+2.70%)

Meetings to be held with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CHRW C.H. Robinson
$99.61 /

+2.615 (+2.70%)

CHRW C.H. Robinson
$99.61 /

+2.615 (+2.70%)

11/30/22 Exane BNP Paribas
C.H. Robinson initiated with an Outperform at Exane BNP Paribas
11/30/22 BofA
RXO Inc. initiated with a Buy at BofA
11/15/22 Raymond James
C.H. Robinson downgraded to Underperform from Market Perform at Raymond James
11/15/22 Raymond James
C.H. Robinson downgraded to Underperform from Market Perform at Raymond James
CHRW C.H. Robinson
$99.61 /

+2.615 (+2.70%)

CHRW C.H. Robinson
$99.61 /

+2.615 (+2.70%)

CHRW C.H. Robinson
$99.61 /

+2.615 (+2.70%)

CHRW C.H. Robinson
$99.61 /

+2.615 (+2.70%)

Conference/Events
TPG RE Finance management to meet with BTIG » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
TRTX

TPG RE Finance

$7.42 /

+0.315 (+4.43%)

Mortgage and Specialty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRTX TPG RE Finance
$7.42 /

+0.315 (+4.43%)

11/21/22 BofA
TPG RE Finance reinstated with a Neutral at BofA
11/02/22 BTIG
TPG RE Finance downgraded to Neutral from Buy at BTIG
10/24/22 JPMorgan
TPG RE Finance price target lowered to $9 from $9.50 at JPMorgan
05/06/22 Citi
TPG RE Finance price target lowered to $12 from $14 at Citi
TRTX TPG RE Finance
$7.42 /

+0.315 (+4.43%)

Conference/Events
Permian Resources management to meet with Truist » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
PR

Permian Resources

$10.16 /

+0.06 (+0.59%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
PR Permian Resources
$10.16 /

+0.06 (+0.59%)

11/17/22 Piper Sandler
Permian Resources price target raised to $15 from $12 at Piper Sandler
10/26/22 Citi
Permian Resources reinstated with a Buy at Citi
10/20/22 JPMorgan
Permian Resources price target lowered to $11 from $12 at JPMorgan
10/18/22 Piper Sandler
Permian Resources price target raised to $12 from $11 at Piper Sandler
PR Permian Resources
$10.16 /

+0.06 (+0.59%)

Conference/Events
Grid Dynamics management to meet with Needham » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
GDYN

Grid Dynamics

$12.77 /

+0.84 (+7.04%)

Meeting to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GDYN Grid Dynamics
$12.77 /

+0.84 (+7.04%)

GDYN Grid Dynamics
$12.77 /

+0.84 (+7.04%)

11/04/22 Citi
Grid Dynamics price target lowered to $18 from $27 at Citi
10/14/22 JPMorgan
Grid Dynamics price target lowered to $22 from $27 at JPMorgan
05/09/22 Northland
Grid Dynamics price target raised to $25 from $22.50 at Northland
05/06/22 Citi
Grid Dynamics price target raised to $23 from $20 at Citi
  • 08
    Sep
GDYN Grid Dynamics
$12.77 /

+0.84 (+7.04%)

Conference/Events
Netgear to hold virtual financial analyst day » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
NTGR

Netgear

$19.76 /

+0.34 (+1.75%)

2022 Virtual Financial…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NTGR Netgear
$19.76 /

+0.34 (+1.75%)

NTGR Netgear
$19.76 /

+0.34 (+1.75%)

07/28/22 BWS Financial
Netgear upgraded to Buy from Neutral at BWS Financial
04/28/22 Deutsche Bank
Netgear price target lowered to $22 from $25 at Deutsche Bank
04/19/22 Cowen
Netgear's Q1 miss suggests challenges to persist, says Cowen
04/18/22 BWS Financial
Netgear price target lowered to $27 from $30 at BWS Financial
NTGR Netgear
$19.76 /

+0.34 (+1.75%)

NTGR Netgear
$19.76 /

+0.34 (+1.75%)

Conference/Events
SharpLink Gaming to host conference call » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
SBET

SharpLink Gaming

/

+

CEO Phythian holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SBET SharpLink Gaming
/

+

SBET SharpLink Gaming
/

+

Conference/Events
Avid Technology management to meet with B. Riley » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
AVID

Avid Technology

$28.09 /

+1.585 (+5.98%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AVID Avid Technology
$28.09 /

+1.585 (+5.98%)

AVID Avid Technology
$28.09 /

+1.585 (+5.98%)

08/03/22 B. Riley
Avid Technology price target lowered to $34 from $45 at B. Riley
07/11/22 Rosenblatt
Avid Technology initiated with a Neutral at Rosenblatt
07/06/22 JPMorgan
Avid Technology initiated with an Overweight at JPMorgan
05/25/22 Northland
Avid Technology price target raised to $53 from $48 at Northland
AVID Avid Technology
$28.09 /

+1.585 (+5.98%)

AVID Avid Technology
$28.09 /

+1.585 (+5.98%)

Conference/Events
First Foundation management to meet with Stephens » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
FFWM

First Foundation

$14.00 /

+0.3 (+2.19%)

Meeting to be held with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FFWM First Foundation
$14.00 /

+0.3 (+2.19%)

FFWM First Foundation
$14.00 /

+0.3 (+2.19%)

10/26/22 DA Davidson
First Foundation downgraded to Neutral from Buy at DA Davidson
07/27/22 B. Riley
First Foundation price target raised to $23 from $21 at B. Riley
07/11/22 B. Riley
First Foundation downgraded to Neutral from Buy at B. Riley
04/12/22 B. Riley
First Foundation price target lowered to $31 from $34 at B. Riley
FFWM First Foundation
$14.00 /

+0.3 (+2.19%)

FFWM First Foundation
$14.00 /

+0.3 (+2.19%)

Conference/Events
Elbit Systems to participate in a conference call with Benchmark » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
ESLT

Elbit Systems

$174.73 /

+7.18 (+4.29%)

Conference call with CFO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ESLT Elbit Systems
$174.73 /

+7.18 (+4.29%)

ESLT Elbit Systems
$174.73 /

+7.18 (+4.29%)

Conference/Events
Shopify management to meet with JMP Securities » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
SHOP

Shopify

$40.86 /

+3.715 (+10.00%)

Luncheon meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SHOP Shopify
$40.86 /

+3.715 (+10.00%)

SHOP Shopify
$40.86 /

+3.715 (+10.00%)

11/29/22 Jefferies
Shopify BFCM results may point to Q4 tracking ahead of consensus, says Jefferies
11/29/22 UBS
Affirm initiated with a Neutral at UBS
11/15/22 MoffettNathanson
Shopify initiated with a Market Perform at MoffettNathanson
10/28/22 Wells Fargo
Shopify price target raised to $42 from $38 at Wells Fargo
SHOP Shopify
$40.86 /

+3.715 (+10.00%)

SHOP Shopify
$40.86 /

+3.715 (+10.00%)

SHOP Shopify
$40.86 /

+3.715 (+10.00%)

SHOP Shopify
$40.86 /

+3.715 (+10.00%)

Conference/Events
Veracyte management to meet virtually with Stephens » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
VCYT

Veracyte

$27.78 /

+2.25 (+8.81%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VCYT Veracyte
$27.78 /

+2.25 (+8.81%)

VCYT Veracyte
$27.78 /

+2.25 (+8.81%)

05/04/22 Needham
Veracyte price target lowered to $26 from $31 at Needham
03/15/22 Needham
Needham drops Veracyte target, says shares undervalued
03/01/22 Lake Street
Veracyte price target lowered to $50 from $95 at Lake Street
03/01/22 Needham
Veracyte price target lowered to $35 from $55 at Needham
VCYT Veracyte
$27.78 /

+2.25 (+8.81%)

VCYT Veracyte
$27.78 /

+2.25 (+8.81%)

Conference/Events
Texas Instruments to participate in a conference call with Benchmark » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
TXN

Texas Instruments

$180.47 /

+7.48 (+4.32%)

Research Analyst Acree…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TXN Texas Instruments
$180.47 /

+7.48 (+4.32%)

TXN Texas Instruments
$180.47 /

+7.48 (+4.32%)

11/15/22 Credit Suisse
Texas Instruments assumed with Neutral from Outperform at Credit Suisse
11/01/22 Craig-Hallum
Lattice Semiconductor price target lowered to $50 from $58 at Craig-Hallum
10/26/22 Susquehanna
Texas Instruments price target lowered to $195 from $215 at Susquehanna
10/26/22 Deutsche Bank
Texas Instruments price target lowered to $155 from $160 at Deutsche Bank
TXN Texas Instruments
$180.47 /

+7.48 (+4.32%)

TXN Texas Instruments
$180.47 /

+7.48 (+4.32%)

TXN Texas Instruments
$180.47 /

+7.48 (+4.32%)

TXN Texas Instruments
$180.47 /

+7.48 (+4.32%)

Conference/Events
Aviat Networks management to meet virtually with B. Riley » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
AVNW

Aviat Networks

$31.42 /

+0.105 (+0.34%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVNW Aviat Networks
$31.42 /

+0.105 (+0.34%)

AVNW Aviat Networks
$31.42 /

+0.105 (+0.34%)

11/03/22 B. Riley
Aviat Networks price target raised to $57 from $56 at B. Riley
09/01/22 JMP Securities
Aviat Networks initiated with an Outperform at JMP Securities
08/24/22 B. Riley
Aviat Networks price target raised to $56 from $55 at B. Riley
06/28/22 Northland
Aviat Networks price target raised to $65 from $55 at Northland
AVNW Aviat Networks
$31.42 /

+0.105 (+0.34%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.